Literature DB >> 3728879

Acrodermatitis chronica atrophicans--a spirochetosis. Clinical and histopathological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius.

E Asbrink, E Brehmer-Andersson, A Hovmark.   

Abstract

The recent discovery that spirochetes transmitted by the tick Ixodes ricinus are involved in the etiology of erythema chronicum migrans Afzelius (ECMA), Bannwarth's syndrome, and acrodermatitis chronica atrophicans (ACA) has thrown new light upon these disorders. Thirty-two patients showing clinical and serological evidence of ACA were investigated. Histologically, constant findings in active ACA lesions were telangiectases and a lymphocytic infiltrate with a moderate to rich admixture of plasma cells. Clinically, besides ACA lesions, lichen sclerosus et atrophicus (LSA)-like lesions were found in five patients. Four of these patients displayed a histopathological picture compatible with LSA. These findings suggest a relationship between ACA and LSA. In six patients spontaneous healing of ECMA was followed by ACA lesions after a latency period of 1-8 years. Six patients reported histories of cranial nerve involvement. Radiography revealed subluxation of joints in hands or feet in six patients, and periosteal thickening in another three patients. The results indicate that ACA may be a late manifestation of infection with the same spirochete that causes ECMA and Bannwarth's syndrome. If untreated, the infection may continue for many years and result in irreversible degenerative lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3728879     DOI: 10.1097/00000372-198606000-00005

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

1.  Two unusual cases of diffuse acrodermatitis chronica atrophicans seronegative for Lyme borreliosis.

Authors:  T G Berger; C Schoerner; H Schell; M Simon; G Schuler; M Röllinghoff; A Gessner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-29       Impact factor: 3.267

Review 2.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

3.  Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay.

Authors:  K Hansen; E Asbrink
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 4.  Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature.

Authors:  J R Goodlad; M M Davidson; P Gordon; R Billington; D O Ho-Yen
Journal:  Mol Pathol       Date:  2002-12

5.  Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; R F Schell
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen.

Authors:  B J Luft; S Mudri; W Jiang; R J Dattwyler; P D Gorevic; T Fischer; P Munoz; J J Dunn; W H Schubach
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

Review 7.  Lyme disease: a growing threat to urban populations.

Authors:  A C Steere
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Innate Immune Memory to Repeated Borrelia burgdorferi Exposure Correlates with Murine In Vivo Inflammatory Phenotypes.

Authors:  Quentin Bernard; Linden T Hu
Journal:  J Immunol       Date:  2020-11-09       Impact factor: 5.422

9.  Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients.

Authors:  K Ogrinc; V Maraspin; L Lusa; T Cerar Kišek; E Ružić-Sabljić; F Strle
Journal:  J Intern Med       Date:  2021-03-13       Impact factor: 13.068

10.  Lyme borreliosis and skin.

Authors:  Biju Vasudevan; Manas Chatterjee
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.